Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology

Abstract Background Xianlinggubao formula (XLGB), a Chinese State Food and Drug Administration-permitted traditional Chinese herbal medicine, has been extensively used to treat osteoporosis. Although XLGB was shown to improve bone mass in ovariectomized rats and clinically alleviate osteoporosis sym...

Full description

Saved in:
Bibliographic Details
Main Authors: Hangsheng Bao (Author), Huizhi Guo (Author), Zongquan Feng (Author), Xin Li (Author)
Format: Book
Published: BMC, 2020-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available